Bendectin and Birth Defects : The Challenges of Mass Toxic Substances Litigation

Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabi...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Green, Michael D. [verfasserIn]

Format:

E-Book

Sprache:

Englisch

Erschienen:

Philadelphia, Pa.: University of Pennsylvania Press ; 2016

©1996

Rechteinformationen:

Restricted Access

Schlagwörter:

Toxic torts, United States

Complex litigation, United States

Bendectin (Trademark), Toxicology

Products liability, Drugs, United States

Bendectin (Trademark).

Complex litigation.

Products liability.

Toxic torts.

LAW / Malpractice

Umfang:

1 online resource

Links:

Link aufrufen
Volltext
Volltext
Link aufrufen
Cover
Cover

ISBN:

978-1-5128-1641-9

DOI / URN:

10.9783/9781512816419

Katalog-ID:

871419890

Nicht das Richtige dabei?

Schreiben Sie uns!